Joel Reiss compensation by year
TransDigm Summary Compensation Table · all 3 fiscal years held| Component | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Salary | $568,333 | $747,750 | $768,140 |
| Bonus | $79,885 | $0 | $0 |
| Stock awards | $0 | $0 | $0 |
| Option awards | $1,578,426 | $12,037,422 | $8,442,541 |
| Non-equity incentive | $532,567 | $879,308 | $905,062 |
| Pension and deferred compensation | $0 | $0 | $0 |
| All other | $837,350 | $7,760,250 | $29,380,469 |
| Total | $3,596,562 | $21,424,730 | $39,496,212 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: TransDigm Group INC DEF 14A filed January 23, 2026, accession 0001260221-26-000009, and prior-year filings.
How this page was built: the TransDigm Group INC filed document, accession 0001260221-26-000009. Every figure is read from that document and cited to the page and table it appears in. Filed January 23, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 6,500 | — | $582.80 |
| Option | 14,300 | — | $643.00 |
| Option | 12,440 | — | $1302.30 |
| Option | 19,080 | — | $869.73 |
Per the Outstanding Equity Awards at Fiscal Year-End table in TransDigm Group INC's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
224 Form 4 lines since the FY2025 proxy (filed January 23, 2026)current to 2026-11-10 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-11-03 | Grant or award derivative | — | 19,250 | $0.00 | 19,250 |
| 2026-10-15 | Sale | 10b5-1 | 50 | $1116.02 | 7,430 |
| 2026-10-15 | Sale | 10b5-1 | 278 | $1125.86 | 5,865 |
| 2026-10-15 | Sale | 10b5-1 | 20 | $1112.27 | 7,680 |
| 2026-10-15 | Sale | 10b5-1 | 305 | $1127.01 | 5,560 |
| 2026-10-15 | Sale | 10b5-1 | 100 | $1114.82 | 7,480 |
| 2026-10-15 | Sale | 10b5-1 | 131 | $1123.09 | 7,049 |
| 2026-10-15 | Sale | 10b5-1 | 100 | $1113.58 | 7,580 |
The 8 most recent of 224 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
TransDigm’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Joel Reiss · this page | Co-Chief Operating Officer | $39,496,212 |
| Michael Lisman | Co-Chief Operating Officer | $33,877,872 |
| Kevin Stein | President, Chief Executive Officer, and Director | $25,188,430 |
| Sarah Wynne | Chief Financial Officer | $15,851,306 |
| Patrick Murphy | Co-Chief Operating Officer | $13,843,634 |
Joel Reiss's compensation dossier, TransDigm
You have read Joel Reiss's totals and holdings. The dossier adds each equity grant TransDigm disclosed for Joel Reiss and TransDigm's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full TransDigm compensation record
free company briefThis page is one person within TransDigm's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the TransDigm proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order TransDigm's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are TransDigm's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.